Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model (Q40382306)
Jump to navigation
Jump to search
scientific article published on August 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model |
scientific article published on August 2005 |
Statements
1 reference
Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model (English)
1 reference
Francisco J Hernandez-Ilizaliturri
1 reference
Nishitha Reddy
1 reference
Beata Holkova
1 reference
Edris Ottman
1 reference
Myron S Czuczman
1 reference
1 August 2005
1 reference
1 reference
Identifiers
1 reference